Alnylam Pharmaceuticals
ALNY
#378
Rank
NZ$104.76 B
Marketcap
NZ$793.01
Share price
-1.55%
Change (1 day)
80.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company